WHO/WHAT: NEOPHARM, Inc. (NASDAQ/NM: NEOL) clinical data presentations on CINTREDEKIN BESUDOTOX ("IL13-PE38QQR")
WHERE: Congress of Neurological Surgeons (CNS) 2006 Annual Meeting
October 7-12, 2006
McCormick Place Convention Center
Chicago, Ill.